1-17 of 17
Laura M. Heiser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB178: Neoplastic immune mimicry is a generalizable phenomenon in breast cancer and epithelial CD69 enables early tumor progression

Free
Eric B. Berens, Sokchea Khou, Elaine Huang, Amber Hoffman, Briana Johnson, Nell Kirchberger, Sam Sivagnanam, Nicholas Calistri, Daniel Derrick, Tiera A. Liby, Ian C. McLean, Aryn A. Alanizi, E. Shelley Hwang, Pepper Schedin, Hugo Gonzalez, Zena Werb, Laura M. Heiser, Lisa M. Coussens
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_2): LB178.
https://doi.org/10.1158/1538-7445.AM2025-LB178
Published: 25 April 2025
View article titled, Abstract LB178: Neoplastic immune mimicry is a generalizable phenomenon in breast cancer and epithelial CD69 enables early tumor progression
Journal Articles

Senescent Cell–Derived Extracellular Vesicles Inhibit Cancer Recurrence by Coordinating Immune Surveillance

Available to Purchase
Tahereh Ziglari, Nicholas L. Calistri, Jennifer M. Finan, Daniel S. Derrick, Ernesto S. Nakayasu, Meagan C. Burnet, Jennifer E. Kyle, Matthew Hoare, Laura M. Heiser, Ferdinando Pucci
Journal: Cancer Research
Cancer Res (2025) 85 (5): 859–874.
https://doi.org/10.1158/0008-5472.CAN-24-0875
Published: 03 March 2025
View article titled, Senescent Cell–Derived Extracellular Vesicles Inhibit Cancer Recurrence by Coordinating Immune Surveillance
Open the PDF for Senescent Cell–Derived Extracellular Vesicles Inhibit Cancer Recurrence by Coordinating Immune Surveillance in another window
Includes: Supplementary data
Journal Articles

Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression

Free
Eric B. Berens, Sokchea Khou, Elaine Huang, Amber Hoffman, Briana Johnson, Zena Werb, Laura M. Heiser, Lisa M. Coussens
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB224.
https://doi.org/10.1158/1538-7445.AM2024-LB224
Published: 05 April 2024
View article titled, Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression
Journal Articles

Abstract IA019: Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit

Free
Laura M. Heiser
Journal: Cancer Research
Cancer Res (2024) 84 (3_Supplement_2): IA019.
https://doi.org/10.1158/1538-7445.CANEVOL23-IA019
Published: 01 February 2024
View article titled, Abstract IA019: Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit
Journal Articles

Integrating Mathematical Modeling with High-Throughput Imaging Explains How Polyploid Populations Behave in Nutrient-Sparse Environments

Available to Purchase
Gregory J. Kimmel, Mark Dane, Laura M. Heiser, Philipp M. Altrock, Noemi Andor
Journal: Cancer Research
Cancer Res (2020) 80 (22): 5109–5120.
https://doi.org/10.1158/0008-5472.CAN-20-1231
Published: 13 November 2020
View article titled, Integrating Mathematical Modeling with High-Throughput Imaging Explains How Polyploid Populations Behave in Nutrient-Sparse Environments
Open the PDF for Integrating Mathematical Modeling with High-Throughput Imaging Explains How Polyploid Populations Behave in Nutrient-Sparse Environments in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract LB-240: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Free
Archana Sehrawat, Dae-Hwan Kim, Lina Gao, Yuliang Wang, Armand Bankhead, Shannon McWeeney, Carly J. King, Jacob Schwartzman, Junior Tayou, Joshua Urrutia, William H. Bisson, Daniel J. Coleman, Sunil K. Joshi, David A. Sampson, Sheila Weinmann, Bhaskar VS Kallakury, Deborah L. Berry, Reina Haque, Stephen K. Van Den Eeden, Sunil Sharma, Jared Bearss, Tomasz M. Beer, George V. Thomas, Laura M. Heiser, Joshi J. Alumkal
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-240.
https://doi.org/10.1158/1538-7445.AM2018-LB-240
Published: 01 July 2018
View article titled, Abstract LB-240: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
Journal Articles

Abstract 2406: LSD1 promotes castration-resistant prostate cancer cell survival independently of the androgen receptor and of histone demethylation

Free
Archana Sehrawat, Lina Gao, Junior Tayou, Armand Bankhead, Laura M. Heiser, Carly J. King, Yuliang Wang, Jacob Schwartzman, Joshua Urrutia, Daniel J. Coleman, Sheila Weinmann, Bhaskar V. Kallakury, Deborah L. Berry, Reina Haque, Stephen K. Van Den Eeden, Tomasz M. Beer, George V. Thomas, Shannon McWeeney, Joshi J. Alumkal
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2406.
https://doi.org/10.1158/1538-7445.AM2017-2406
Published: 01 July 2017
View article titled, Abstract 2406: LSD1 promotes castration-resistant prostate cancer cell survival independently of the androgen receptor and of histone demethylation
Journal Articles

Abstract 4700: BET bromodomain inhibition is a promising treatment strategy for distinct subsets of lethal castration-resistant prostate cancer

Free
Lina Gao, Daniel J. Coleman, Carly J. King, Jacob Schwartzman, Nicholas Wang, Amanda Esch, Joshua Urrutia, Archana Sehrawat, Laura M. Heiser, Joshi J. Alumkal
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4700.
https://doi.org/10.1158/1538-7445.AM2016-4700
Published: 15 July 2016
View article titled, Abstract 4700: BET bromodomain inhibition is a promising treatment strategy for distinct subsets of lethal castration-resistant prostate cancer
Journal Articles

Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells

Free
Lanfang Qin, Maria B Hahn, Xiaoyong Fu, Martin J Shea, Mario Giuliano, Sarmistha Nanda, Xiaowei Xu, Huizhong Hu, Sung Yun Jung, Laura M Heiser, Nicholas Wang, Joe W Gray, Susan G Hilsenbeck, Chad Creighton, Chad A Shaw, Gary C Chamness, Dean P Edwards, Sabrina Herrera, Carolina Gutierrez, C Kent Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-05-13.
https://doi.org/10.1158/1538-7445.SABCS14-P3-05-13
Published: 01 May 2015
View article titled, Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells
Journal Articles

Abstract P5-05-01: Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance

Free
Huizhong Hu, Lukas M Simon, Agostina Nardone, Chad A Shaw, Gary C Chamness, Laura M Heiser, Nicholas Wang, C Kent Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-05-01.
https://doi.org/10.1158/1538-7445.SABCS14-P5-05-01
Published: 01 May 2015
View article titled, Abstract P5-05-01: Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance
Journal Articles

Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib

Free
Xiaowei Xu, Agostina Nardone, Huizhong Hu, Lanfang Qin, Sarmistha Nanda, Laura M Heiser, Nicholas Wang, Kyle R Covington, Edward S Chen, Alexander Renwick, Tao Wang, Carmine De Angelis, Alejandro Contreras, Carolina Gutierrez, Suzanne AW Fuqua, Gary C Chamness, Chad Shaw, David A Wheeler, Joe W Gray, Susan G Hilsenbeck, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-05-03.
https://doi.org/10.1158/1538-7445.SABCS14-P5-05-03
Published: 01 May 2015
View article titled, Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib
Journal Articles

Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8

Free
Xiaoyong Fu, Rinath Jeselsohn, Emporia F Hollingsworth, Dolores Lopez-Terrada, Chad J Creighton, Agostina Nardone, Martin Shea, Laura M Heiser, Pavana Anur, Nicholas Wang, Catie Grasso, Paul Spellman, Carolina Gutierrez, Mothaffar F Rimawi, Susan G Hilsenbeck, Joe W Gray, Myles Brown, C K Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD6-2.
https://doi.org/10.1158/1538-7445.SABCS14-PD6-2
Published: 01 May 2015
View article titled, Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8
Journal Articles

Abstract A58: Wnt signaling pathway components are associated with telomerase activity in breast cancer

Free
Imke Listerman, Francesca S. Gazzaniga, Laura M. Heiser, Jason J. Lukas, Ted Goldstein, David Haussler, Joe W. Gray, Elizabeth H. Blackburn
Journal: Cancer Research
Cancer Res (2011) 71 (18_Supplement): A58.
https://doi.org/10.1158/1538-7445.FBCR11-A58
Published: 28 October 2014
View article titled, Abstract A58: Wnt signaling pathway components are associated with telomerase activity in breast cancer
Journal Articles

Abstract 5502: Metrics other than potency reveal systematic variation in responses to cancer drugs

Free
Mohammad Fallahi-Sichani, Saman Honarnejad, Laura M. Heiser, Joe W. Gray, Peter K. Sorger
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5502.
https://doi.org/10.1158/1538-7445.AM2014-5502
Published: 01 October 2014
View article titled, Abstract 5502: Metrics other than potency reveal systematic variation in responses to cancer drugs
Journal Articles

Abstract 5238: Acquired therapeutic resistance is mediated by deregulation of multiple pathways.

Free
Laura M. Heiser, Chad A. Shaw, Nicholas J. Wang, Catie Grasso, Pavana Anur, Sam Ng, Theodore Goldstein, Paul T. Spellman, Joshua Stuart, Kent Osborne, Joe Gray, Rachel Schiff
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5238.
https://doi.org/10.1158/1538-7445.AM2013-5238
Published: 15 April 2013
View article titled, Abstract 5238: Acquired therapeutic resistance is mediated by deregulation of multiple pathways.
Journal Articles

Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines

Free
James Korkola, Nora Bayani, Brian Cooper, Laura M. Heiser, Paul T. Spellman, Heidi S. Feiler, Richard Wooster, Joe W. Gray
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 639.
https://doi.org/10.1158/1538-7445.AM2011-639
Published: 15 April 2011
View article titled, Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines
Journal Articles

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Free
Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser, Sanchita Bhattacharya, Doris Siwak, Rina Gendelman, Nora Bayani, Nicholas J. Wang, Richard M. Neve, Yinghui Guan, Zhi Hu, Zachary Knight, Heidi S. Feiler, Philippe Gascard, Bahram Parvin, Paul T. Spellman, Kevan M. Shokat, Andrew J. Wyrobek, Mina J. Bissell, Frank McCormick, Wen-Lin Kuo, Gordon B. Mills, Joe W. Gray, W. Michael Korn
Journal: Cancer Research
Cancer Res (2009) 69 (2): 565–572.
https://doi.org/10.1158/0008-5472.CAN-08-3389
Published: 15 January 2009
View article titled, Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
Open the PDF for Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition in another window
Includes: Supplementary data